Article
Heterogeneity of ryanodine receptor dysfunction in a mouse model of catecholaminergic polymorphic ventricular tachycardia.
Circulation research - 18 Jan 2013
Loaiza Randall, Benkusky Nancy A, Powers Patricia P, Hacker Timothy, Noujaim Sami, Ackerman Michael J, Jalife José, Valdivia Héctor H
Abstract excerpt
RATIONALE: Most cardiac ryanodine receptor (RyR2) mutations associated with catecholaminergic polymorphic ventricular tachycardia (CPVT) are postulated to cause a distinctive form of Ca(2+) release dysfunction. Considering the spread distribution of CPVT mutations, we hypothesized that dysfunctional heterogeneity also was feasible. OBJECTIVE: To determine the molecular and cellular mechanisms by which a novel...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
